Trial Profile
Assessing Bioavailability of CoQ10 Supplementation in Intensive Care Patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2022
Price :
$35
*
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 01 Sep 2020 Status changed to active, no longer recruiting.
- 26 Aug 2015 New trial record